Atrium Therapeutics, Inc. (RNA)
10.36
-0.15
(-1.43%)
USD |
NASDAQ |
Sep 10, 16:00
10.36
0.00 (0.00%)
After-Hours: 18:09
Atrium Therapeutics Total Assets (Quarterly) : 280.51M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 280.51M |
| March 31, 2026 | 292.36M |
| December 31, 2025 | 8.948M |
| Date | Value |
|---|---|
| June 30, 2025 | |
| March 31, 2025 | |
| December 31, 2024 | 8.732M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | 121.66M |
| Exicure, Inc. | 11.40M |
| Century Therapeutics, Inc. | 287.01M |
| Absci Corp. | 268.92M |
| Celularity, Inc. | 302.90M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 65.94M |
| Shareholders Equity (Quarterly) | 214.58M |
| Debt to Equity Ratio | 0.0078 |
| Current Ratio | 8.730 |
| Net Debt Paydown Yield | 0.44% |